Tissue360 Newsletter
Archive/Subscribe | TAPPI.org | Advertise | TAPPI Press Catalog May 2021

Essity Presents Additional Information Regarding its Manufacturing Roadmap Program

Print Print this Article | Send to Colleague

Hygiene and health company Essity today presents additional information regarding the program Manufacuring Roadmap, including optimizing and streamlining all of the group’s approximately 60 wholly owned production facilities and logistics and distribution. The program extends until 2025 and is expected to contribute to Essity’s total annual cost savings of SEK 500-1,000m through the optimization of the production structure, productivity improvements and raw material and energy savings.

These measures facilitate growth without investments increasing at the same pace. Working capital is expected to decrease by more than SEK 1,000m. The objective is to also utilize new production methods to reduce exposure to wood-based fresh-fiber pulp by approximately 10 percent, which will result in reduced volatility for the company’s profitability.

“With the program "Manufacturing Roadmap", we streamline Essity's supply chain. We will achieve even higher quality and service levels to customers and consumers while reducing our environmental footprint and strengthen our profitability”, says Magnus Groth, president and CEO of Essity.

The program will also lead to that the company’s sustainability targets within the Science Based Targets will be achieved faster. A recent example is that Essity replaced natural gas with biogas at the company’s Lilla Edet tissue plant in Sweden, reducing fossil CO2 emissions to zero during normal operations.

 

Back to Tissue360 Newsletter

 
American Roller and Plasma Coatings
Köerber Tissue
Industrial Shredders Ltd